Jan. 6, 1968 marks the 50-year anniversary of the first human heart transplant in the United States, which happened here at Stanford.
Since becoming chair of dermatology in 2010, Stanford's Paul Khavari has built his department like a sports team owner looking for winning seasons.
Loss of taste sensation occurs in about 85 percent of cancer patients receiving chemotherapy. A new Stanford study explored the problem.
A glance at the most popular Stanford Medicine magazine articles of the year.
A look at the most popular Scope pieces of the year.
Stanford neuroscientist Ben Barres devoted his career to studying glial cells, which play a significant, but previously undervalued, role in the brain.
People with food allergies can be gradually desensitized to foods that trigger reactions, clinical trials at Stanford’s Sean N. Parker Center for Allergy and Asthma Research have shown.
A look at the medical applications of a cooling technique that improves athletic performance.
Doctors and patients can preview brain and spine procedures via virtual reality at the at the Stanford Neurosurgical Simulation and Virtual Reality Center.
Immune cells spot cancer cells by locating proteins called antigens. Now, researchers have developed a new tool that will help them identify those antigens.
By identifying abnormally expressed proteins in the eye, a Stanford-led team matched existing drugs with these proteins to quell patients' symptoms.
To quit smoking, medications and patches may not be enough, a study has found.
Kidney stones are more common in warm, wet regions. Stanford urology resident Kai Dallas offers a possible explanation.
Just imagine if you could predict and prevent a burst of binge eating or alcohol intake, a heroin injection, a sudden bout of uncontrolled rage or …
It takes time and money to visit the doctor’s office to get birth control. This is particularly an issue for low-income women, those who live …
A team of Stanford researchers is developing approaches to thwart a family of deadly viruses called flaviviruses, by targeting the human cells that host these invading …